{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T01:00:34Z","timestamp":1792544434577,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T00:00:00Z","timestamp":1596672000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Am J Clin Dermatol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1007\/s40257-020-00537-9","type":"journal-article","created":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T09:03:49Z","timestamp":1596704629000},"page":"741-748","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study"],"prefix":"10.1007","volume":"21","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6783-4534","authenticated-orcid":false,"given":"\u00d8ystein","family":"Grimstad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn \u00d8ivind","family":"Kvammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Swartling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,6]]},"reference":[{"issue":"1062","key":"537_CR1","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1136\/postgradmedj-2013-131994","volume":"90","author":"DN Dufour","year":"2014","unstructured":"Dufour DN, Emtestam L, Jemec GB. Hidradenitis suppurativa: a common and burdensome, yet under-recognised, inflammatory skin disease. Postgrad Med J. 2014;90(1062):216\u201321. https:\/\/doi.org\/10.1136\/postgradmedj-2013-131994.","journal-title":"Postgrad Med J"},{"issue":"2","key":"537_CR2","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/nejmcp1014163","volume":"366","author":"GB Jemec","year":"2012","unstructured":"Jemec GB. Clinical practice. Hidradenitis suppurativa. N Engl J Med. 2012;366(2):158\u201364. https:\/\/doi.org\/10.1056\/nejmcp1014163.","journal-title":"N Engl J Med"},{"issue":"5 Suppl 1","key":"537_CR3","doi-asserted-by":"publisher","first-page":"S8","DOI":"10.1016\/j.jaad.2015.07.045","volume":"73","author":"E Prens","year":"2015","unstructured":"Prens E, Deckers I. Pathophysiology of hidradenitis suppurativa: an update. J Am Acad Dermatol. 2015;73(5 Suppl 1):S8\u201311. https:\/\/doi.org\/10.1016\/j.jaad.2015.07.045.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"537_CR4","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1111\/bjd.16101","volume":"178","author":"JR Ingram","year":"2018","unstructured":"Ingram JR, Jenkins-Jones S, Knipe DW, Morgan CLI, Cannings-John R, Piguet V. Population-based Clinical Practice Research Datalink study using algorithm modelling to identify the true burden of hidradenitis suppurativa. Br J Dermatol. 2018;178(4):917\u201324. https:\/\/doi.org\/10.1111\/bjd.16101.","journal-title":"Br J Dermatol"},{"issue":"1","key":"537_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jaad.2009.02.013","volume":"61","author":"F Canoui-Poitrine","year":"2009","unstructured":"Canoui-Poitrine F, Revuz JE, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al. Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity. J Am Acad Dermatol. 2009;61(1):51\u20137.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"537_CR6","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.jaad.2008.06.020","volume":"59","author":"JE Revuz","year":"2008","unstructured":"Revuz JE, Canoui-Poitrine F, Wolkenstein P, Viallette C, Gabison G, Pouget F, et al. Prevalence and factors associated with hidradenitis suppurativa: results from two case-control studies. J Am Acad Dermatol. 2008;59(4):596\u2013601. https:\/\/doi.org\/10.1016\/j.jaad.2008.06.020.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"537_CR7","doi-asserted-by":"publisher","first-page":"55","DOI":"10.12788\/j.sder.2017.018","volume":"36","author":"ML Porter","year":"2017","unstructured":"Porter ML, Kimball AB. Comorbidities of hidradenitis suppurativa. Semin Cutan Med Surg. 2017;36(2):55\u20137. https:\/\/doi.org\/10.12788\/j.sder.2017.018.","journal-title":"Semin Cutan Med Surg."},{"issue":"4","key":"537_CR8","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1111\/jdv.12966","volume":"29","author":"CC Zouboulis","year":"2015","unstructured":"Zouboulis CC, Desai N, Emtestam L, Hunger RE, Ioannides D, Juhasz I, et al. European S1 guideline for the treatment of hidradenitis suppurativa\/acne inversa. J Eur Acad Dermatol Venereol. 2015;29(4):619\u201344. https:\/\/doi.org\/10.1111\/jdv.12966.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"3","key":"537_CR9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s11154-016-9328-5","volume":"17","author":"W Gulliver","year":"2016","unstructured":"Gulliver W, Zouboulis CC, Prens E, Jemec GB, Tzellos T. Evidence-based approach to the treatment of hidradenitis suppurativa\/acne inversa, based on the European guidelines for hidradenitis suppurativa. Rev Endocr Metab Disord. 2016;17(3):343\u201351. https:\/\/doi.org\/10.1007\/s11154-016-9328-5.","journal-title":"Rev Endocr Metab Disord."},{"issue":"5","key":"537_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1056\/NEJMoa1504370","volume":"375","author":"AB Kimball","year":"2016","unstructured":"Kimball AB, Okun MM, Williams DA, Gottlieb AB, Papp KA, Zouboulis CC, et al. Two phase 3 trials of adalimumab for hidradenitis suppurativa. N Engl J Med. 2016;375(5):422\u201334. https:\/\/doi.org\/10.1056\/NEJMoa1504370.","journal-title":"N Engl J Med"},{"issue":"12","key":"537_CR11","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1111\/jdv.13772","volume":"30","author":"E Forbat","year":"2016","unstructured":"Forbat E, Ali FR, Al-Niaimi F. Non-cosmetic dermatological uses of botulinum neurotoxin. J Eur Acad Dermatol Venereol. 2016;30(12):2023\u20139. https:\/\/doi.org\/10.1111\/jdv.13772.","journal-title":"J Eur Acad Dermatol Venereol."},{"issue":"12","key":"537_CR12","doi-asserted-by":"publisher","first-page":"403","DOI":"10.3390\/toxins9120403","volume":"9","author":"YS Kim","year":"2017","unstructured":"Kim YS, Hong ES, Kim HS. Botulinum toxin in the field of dermatology: novel indications. Toxins. 2017;9(12):403. https:\/\/doi.org\/10.3390\/toxins9120403.","journal-title":"Toxins."},{"issue":"6","key":"537_CR13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.2340\/00015555-1606","volume":"93","author":"A Rystedt","year":"2013","unstructured":"Rystedt A, Karlqvist M, Bertilsson M, Naver H, Swartling C. Effect of botulinum toxin concentration on reduction in sweating: a randomized, double-blind study. Acta Derm Venereol. 2013;93(6):674\u20138. https:\/\/doi.org\/10.2340\/00015555-1606.","journal-title":"Acta Derm Venereol."},{"key":"537_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/dth.12841","author":"A Campanati","year":"2019","unstructured":"Campanati A, Martina E, Giuliodori K, Bobyr I, Consales V, Offidani A. Two cases of Hidradenitis suppurativa and botulinum toxin type a therapy: a novel approach for a pathology that is still difficult to manage. Dermatol Ther. 2019. https:\/\/doi.org\/10.1111\/dth.12841.","journal-title":"Dermatol Ther"},{"issue":"6","key":"537_CR15","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/ced.12380","volume":"39","author":"AB Khoo","year":"2014","unstructured":"Khoo AB, Burova EP. Hidradenitis suppurativa treated with Clostridium botulinum toxin A. Clin Exp Dermatol. 2014;39(6):749\u201350. https:\/\/doi.org\/10.1111\/ced.12380.","journal-title":"Clin Exp Dermatol"},{"issue":"8","key":"537_CR16","doi-asserted-by":"publisher","first-page":"1300","DOI":"10.1111\/j.1524-4725.2009.01231.x","volume":"35","author":"M Feito-Rodriguez","year":"2009","unstructured":"Feito-Rodriguez M, Sendagorta-Cudos E, Herranz-Pinto P, de Lucas-Laguna R. Prepubertal hidradenitis suppurativa successfully treated with botulinum toxin A. Dermatol Surg. 2009;35(8):1300\u20132. https:\/\/doi.org\/10.1111\/j.1524-4725.2009.01231.x.","journal-title":"Dermatol Surg"},{"issue":"5","key":"537_CR17","doi-asserted-by":"publisher","first-page":"1575","DOI":"10.1097\/01.prs.0000184354.32111.dc","volume":"116","author":"DJ O\u2019Reilly","year":"2005","unstructured":"O\u2019Reilly DJ, Pleat JM, Richards AM. Treatment of hidradenitis suppurativa with botulinum toxin A. Plast Reconstr Surg. 2005;116(5):1575\u20136.","journal-title":"Plast Reconstr Surg"},{"issue":"3","key":"537_CR18","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jaad.2019.08.046","volume":"82","author":"VJ Hua","year":"2020","unstructured":"Hua VJ, Kuo KY, Cho HG, Sarin KY. Hyperhidrosis affects quality of life in hidradenitis suppurativa: a prospective analysis. J Am Acad Dermatol. 2020;82(3):753\u201364. https:\/\/doi.org\/10.1016\/j.jaad.2019.08.046.","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"537_CR19","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1111\/j.0022-202X.2005.23621.x","volume":"125","author":"Y Hongbo","year":"2005","unstructured":"Hongbo Y, Thomas CL, Harrison MA, Salek MS, Finlay AY. Translating the science of quality of life into practice: what do dermatology life quality index scores mean? J Investig Dermatol. 2005;125(4):659\u201364. https:\/\/doi.org\/10.1111\/j.0022-202X.2005.23621.x.","journal-title":"J Investig Dermatol"},{"issue":"3","key":"537_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1111\/bjd.16672","volume":"179","author":"L Thorlacius","year":"2018","unstructured":"Thorlacius L, Ingram JR, Villumsen B, Esmann S, Kirby JS, Gottlieb AB, et al. A core domain set for hidradenitis suppurativa trial outcomes: an international Delphi process. Br J Dermatol. 2018;179(3):642\u201350. https:\/\/doi.org\/10.1111\/bjd.16672.","journal-title":"Br J Dermatol"},{"issue":"9","key":"537_CR21","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1590\/1806-9282.62.09.843","volume":"62","author":"AY Varella","year":"2016","unstructured":"Varella AY, Fukuda JM, Teivelis MP, Campos JR, Kauffman P, Cucato GG, et al. Translation and validation of hyperhidrosis disease severity scale. Revist Assoc Med Bras. 2016;62(9):843\u20137. https:\/\/doi.org\/10.1590\/1806-9282.62.09.843.","journal-title":"Revist Assoc Med Bras"},{"issue":"3","key":"537_CR22","doi-asserted-by":"publisher","first-page":"563","DOI":"10.2307\/2530041","volume":"38","author":"GG Koch","year":"1982","unstructured":"Koch GG, Amara IA, Davis GW, Gillings DB. A review of some statistical methods for covariance analysis of categorical data. Biometrics. 1982;38(3):563\u201395.","journal-title":"Biometrics."},{"issue":"4","key":"537_CR23","doi-asserted-by":"publisher","first-page":"e0151990","DOI":"10.1371\/journal.pone.0151990","volume":"11","author":"GI Perez Perez","year":"2016","unstructured":"Perez Perez GI, Gao Z, Jourdain R, Ramirez J, Gany F, Clavaud C, et al. Body site is a more determinant factor than human population diversity in the healthy skin microbiome. PLoS One. 2016;11(4):e0151990. https:\/\/doi.org\/10.1371\/journal.pone.0151990.","journal-title":"PLoS One."},{"issue":"4","key":"537_CR24","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrmicro2537","volume":"9","author":"EA Grice","year":"2011","unstructured":"Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244\u201353. https:\/\/doi.org\/10.1038\/nrmicro2537.","journal-title":"Nat Rev Microbiol"},{"issue":"5","key":"537_CR25","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1111\/j.1365-2133.2011.10765.x","volume":"166","author":"VU Emelianov","year":"2012","unstructured":"Emelianov VU, Bechara FG, Glaser R, Langan EA, Taungjaruwinai WM, Schroder JM, et al. Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa\/acne inversa. Br J Dermatol. 2012;166(5):1023\u201334. https:\/\/doi.org\/10.1111\/j.1365-2133.2011.10765.x.","journal-title":"Br J Dermatol"},{"issue":"3","key":"537_CR26","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1111\/j.1365-2133.2008.08740.x","volume":"159","author":"SL Lindsay","year":"2008","unstructured":"Lindsay SL, Holmes S, Corbett AD, Harker M, Bovell DL. Innervation and receptor profiles of the human apocrine (epitrichial) sweat gland: routes for intervention in bromhidrosis. Br J Dermatol. 2008;159(3):653\u201360. https:\/\/doi.org\/10.1111\/j.1365-2133.2008.08740.x.","journal-title":"Br J Dermatol"},{"issue":"1 Pt 2","key":"537_CR27","doi-asserted-by":"publisher","first-page":"R181","DOI":"10.1152\/ajpregu.1987.252.1.R181","volume":"252","author":"K Sato","year":"1987","unstructured":"Sato K, Sato F. Sweat secretion by human axillary apoeccrine sweat gland in vitro. Am J Physiol. 1987;252(1 Pt 2):R181\u20137. https:\/\/doi.org\/10.1152\/ajpregu.1987.252.1.R181.","journal-title":"Am J Physiol"},{"issue":"12","key":"537_CR28","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1097\/dss.0000000000001906","volume":"45","author":"CJ Wu","year":"2019","unstructured":"Wu CJ, Chang CK, Wang CY, Liao YS, Chen SG. Efficacy and safety of botulinum toxin a in axillary bromhidrosis and associated histological changes in sweat glands: a prospective randomized double-blind side-by-side comparison clinical study. Dermatol Surg. 2019;45(12):1605\u20139. https:\/\/doi.org\/10.1097\/dss.0000000000001906.","journal-title":"Dermatol Surg"},{"issue":"2","key":"537_CR29","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s00266-018-1075-4","volume":"42","author":"T Wang","year":"2018","unstructured":"Wang T, Dong J, He J. Long-term safety and efficacy of botulinum toxin A treatment in adolescent patients with axillary bromhidrosis. Aesth Plast Surg. 2018;42(2):560\u20134. https:\/\/doi.org\/10.1007\/s00266-018-1075-4.","journal-title":"Aesth Plast Surg"},{"issue":"6","key":"537_CR30","doi-asserted-by":"publisher","first-page":"461","DOI":"10.3109\/09546634.2011.594869","volume":"23","author":"J He","year":"2012","unstructured":"He J, Wang T, Dong J. A close positive correlation between malodor and sweating as a marker for the treatment of axillary bromhidrosis with Botulinum toxin A. J Dermatol Treat. 2012;23(6):461\u20134. https:\/\/doi.org\/10.3109\/09546634.2011.594869.","journal-title":"J Dermatol Treat"},{"issue":"1\u20132","key":"537_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.pain.2003.10.008","volume":"107","author":"M Cui","year":"2004","unstructured":"Cui M, Khanijou S, Rubino J, Aoki KR. Subcutaneous administration of botulinum toxin A reduces formalin-induced pain. Pain. 2004;107(1\u20132):125\u201333.","journal-title":"Pain."},{"issue":"5","key":"537_CR32","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.neuro.2005.01.017","volume":"26","author":"KR Aoki","year":"2005","unstructured":"Aoki KR. Review of a proposed mechanism for the antinociceptive action of botulinum toxin type A. Neurotoxicology. 2005;26(5):785\u201393. https:\/\/doi.org\/10.1016\/j.neuro.2005.01.017.","journal-title":"Neurotoxicology."},{"issue":"2","key":"537_CR33","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1111\/bph.13366","volume":"173","author":"Z Lackovic","year":"2016","unstructured":"Lackovic Z, Filipovic B, Matak I, Helyes Z. Activity of botulinum toxin type A in cranial dura: implications for treatment of migraine and other headaches. Br J Pharmacol. 2016;173(2):279\u201391. https:\/\/doi.org\/10.1111\/bph.13366.","journal-title":"Br J Pharmacol."},{"issue":"4","key":"537_CR34","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1016\/j.pain.2013.12.009","volume":"155","author":"MJ Marino","year":"2014","unstructured":"Marino MJ, Terashima T, Steinauer JJ, Eddinger KA, Yaksh TL, Xu Q. Botulinum toxin B in the sensory afferent: transmitter release, spinal activation, and pain behavior. Pain. 2014;155(4):674\u201384. https:\/\/doi.org\/10.1016\/j.pain.2013.12.009.","journal-title":"Pain."},{"issue":"4","key":"537_CR35","doi-asserted-by":"publisher","first-page":"134","DOI":"10.3390\/toxins10040134","volume":"10","author":"R Ramachandran","year":"2018","unstructured":"Ramachandran R, Marino MJ, Paul S, Wang Z, Mascarenhas NL, Pellett S, et al. A study and review of effects of botulinum toxins on mast cell dependent and independent pruritus. Toxins. 2018;10(4):134. https:\/\/doi.org\/10.3390\/toxins10040134.","journal-title":"Toxins."},{"issue":"4","key":"537_CR36","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1007\/s00403-019-01910-3","volume":"311","author":"EK List","year":"2019","unstructured":"List EK, Pascual JC, Zarchi K, Nurnberg BM, Jemec GBE. Mast cells in hidradenitis suppurativa: a clinicopathological study. Arch Dermatol Res. 2019;311(4):331\u20135. https:\/\/doi.org\/10.1007\/s00403-019-01910-3.","journal-title":"Arch Dermatol Res"},{"issue":"Pt A","key":"537_CR37","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.toxicon.2015.08.001","volume":"107","author":"AR Bentivoglio","year":"2015","unstructured":"Bentivoglio AR, Del Grande A, Petracca M, Ialongo T, Ricciardi L. Clinical differences between botulinum neurotoxin type A and B. Toxicon. 2015;107(Pt A):77\u201384. https:\/\/doi.org\/10.1016\/j.toxicon.2015.08.001.","journal-title":"Toxicon."},{"issue":"24\u201325","key":"537_CR38","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1016\/j.lfs.2007.02.007","volume":"80","author":"A Hana","year":"2007","unstructured":"Hana A, Booken D, Henrich C, Gratchev A, Maas-Szabowski N, Goerdt S, et al. Functional significance of non-neuronal acetylcholine in skin epithelia. Life Sci. 2007;80(24\u201325):2214\u201320. https:\/\/doi.org\/10.1016\/j.lfs.2007.02.007.","journal-title":"Life Sci"},{"issue":"9","key":"537_CR39","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1152\/jappl.1952.4.9.745","volume":"4","author":"M Wada","year":"1952","unstructured":"Wada M, Arai T, Takagaki T, Nakagawa T. Axon reflex mechanism in sweat responses to nicotine, acetylcholine and sodium chloride. J Appl Physiol. 1952;4(9):745\u201352. https:\/\/doi.org\/10.1152\/jappl.1952.4.9.745.","journal-title":"J Appl Physiol"},{"issue":"12","key":"537_CR40","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1111\/jdv.12846","volume":"29","author":"S Molin","year":"2015","unstructured":"Molin S, Ruzicka T, Herzinger T. Smoking is associated with combined allergic and irritant hand eczema, contact allergies and hyperhidrosis. J Eur Acad Dermatol Venereol. 2015;29(12):2483\u20136. https:\/\/doi.org\/10.1111\/jdv.12846.","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"537_CR41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1159\/000472252","volume":"233","author":"J Boer","year":"2017","unstructured":"Boer J. Should hidradenitis suppurativa be included in dermatoses showing koebnerization? Is it friction or fiction? Dermatology. 2017;233(1):47\u201352. https:\/\/doi.org\/10.1159\/000472252.","journal-title":"Dermatology."},{"issue":"3","key":"537_CR42","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.clindermatol.2013.11.006","volume":"32","author":"C Dessinioti","year":"2014","unstructured":"Dessinioti C, Katsambas A, Antoniou C. Hidradenitis suppurrativa (acne inversa) as a systemic disease. Clin Dermatol. 2014;32(3):397\u2013408. https:\/\/doi.org\/10.1016\/j.clindermatol.2013.11.006.","journal-title":"Clin Dermatol."},{"issue":"2","key":"537_CR43","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.jaad.2003.12.040","volume":"51","author":"DR Strutton","year":"2004","unstructured":"Strutton DR, Kowalski JW, Glaser DA, Stang PE. US prevalence of hyperhidrosis and impact on individuals with axillary hyperhidrosis: results from a national survey. J Am Acad Dermatol. 2004;51(2):241\u20138. https:\/\/doi.org\/10.1016\/j.jaad.2003.12.040.","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"537_CR44","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jaad.2019.01.019","volume":"81","author":"N Astman","year":"2019","unstructured":"Astman N, Friedberg I, Wikstrom JD, Derazne E, Pinhas-Hamiel O, Afek A, et al. The association between obesity and hyperhidrosis: a nationwide, cross-sectional study of 2.77 million Israeli adolescents. J Am Acad Dermatol. 2019;81(2):624\u20137. https:\/\/doi.org\/10.1016\/j.jaad.2019.01.019.","journal-title":"J Am Acad Dermatol"}],"container-title":["American Journal of Clinical Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-020-00537-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40257-020-00537-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40257-020-00537-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,5]],"date-time":"2021-08-05T19:13:26Z","timestamp":1628190806000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40257-020-00537-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,6]]},"references-count":44,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1007\/s40257-020-00537-9","relation":{},"ISSN":["1175-0561","1179-1888"],"issn-type":[{"value":"1175-0561","type":"print"},{"value":"1179-1888","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,6]]},"assertion":[{"value":"6 August 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was funded by the University Hospital of North Norway and the University Hospital in Uppsala, Sweden. The statistical analyses were performed by a professional statistician at the Uppsala Clinical Research Centre, Uppsala, Sweden.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"Carl Swartling is a shareholder in Hidros International and is the owner of sweat clinics in Stockholm and Oslo. \u00d8ystein Grimstad and Bj\u00f8rn \u00d8ivind Kvammen report no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the ethical standards of the responsible committees and the Declaration of Helsinki, and with the International Conference on Harmonization Guidelines for Good Clinical Practice. The trial was overseen by an independent Data and Safety Monitoring Board.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The Regional Committee for Medical and Health Research Ethics in North Norway granted ethical approval\u00a0(2017\/149\/REK Nord).","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Institutional Review Board Approval Status"}},{"value":"Written informed consent was obtained from all patients or their proxies.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The datasets generated and\/or analysed during the current study are available from the corresponding author upon reasonable request.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability Statement"}},{"value":"Not applicable.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code Availability"}}]}}